Clinical Trial

Artificial Intelligence-Assisted Learning for Nursing Drug Calculation

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate how an Artificial Intelligence -assisted learning platform affects nurses' ability to calculate medication dosages accurately. Drug calculation is a critical skill in nursing, and errors can significantly impact patient safety. While traditional teaching methods are standard, they may not provide the personalized feedback needed for such a high-stakes task. This study compares two groups of nurses: one group using an Artificial Intelligence-driven software that provides interactive scenarios and real-time guidance, and another group receiving traditional classroom instruction. The researchers aim to determine whether the AI approach leads to: Improved theoretical knowledge of drug calculations. Enhanced clinical decision-making during medication administration. Increased nurses' confidence (self-efficacy) in performing these tasks in real clinical settings. In addition, a qualitative component conducted using focus group discussions to explore participants' acceptance, perceived usefulness, usability, and overall perceptions of the AI-assisted learning platform. This qualitative inquiry provides a deeper insight into nurses' experiences, attitudes toward AI integration in education, and their opinions regarding the effectiveness of the teaching and learning strategies used within the platform.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-28.
Trial Details
NCT Number NCT07448259
Lead Sponsor Alexandria University
Conditions Nursing Education, Clinical Competence, Medication Errors
Enrollment 56 participants
Start Date 2025-09-22
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-01